
Seven Pharma Companies, Including Lilly and Regeneron, Chosen for FDA PreCheck Pilot Program to Strengthen US Drug Supply Chain
Seven pharma companies, including industry leaders Lilly and Regeneron, have been selected for the FDA PreCheck pilot program aimed at enhancing the resilience of the US drug supply chain. This initiative is a positive step towards ensuring the efficiency and reliability of pharmaceutical production in America, benefiting workers, companies, and the overall industry.












